61-year-old female with triple-negative breast cancer of the right
4.7 (799) · $ 11.00 · In stock
Frontiers Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
PDF) MRI as a biomarker for breast cancer diagnosis and prognosis
Rubina TRIMBOLI, PhD Student, University of Milan, Milan, UNIMI, Department of Biomedical Sciences for Health
Triple Negative Breast Cancer
Breast Cancer Survival Rates: Prognosis by Age, Race & More
PDF) MRI as a biomarker for breast cancer diagnosis and prognosis
/publication/358074692/figure/
Frontiers Patterns of de novo metastasis and survival outcomes by age in breast cancer patients: a SEER population-based study
Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants
Targeting Advanced Triple-Negative Breast Cancer
,aspect=fit)
